BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 26097612)

  • 1. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
    Sekiguchi Y; Shirane S; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2015; 8(4):4186-203. PubMed ID: 26097612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature.
    Sekiguchi Y; Matsuzawa N; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Izutsu K; Takeuchi K; Ohta Y; Komatsu N; Noguchi M
    Int J Hematol; 2013 Aug; 98(2):250-7. PubMed ID: 23846384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS).
    Kawanishi K; Ohyama Y; Kanai Y; Hirase T; Tanaka H; Miyatake J; Tatsumi Y; Ashida T; Nakamine H; Matsumura I
    Intern Med; 2012; 51(15):2015-20. PubMed ID: 22864129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Follicular Lymphoma and Myelofibrosis: Report of a Case with Review of the Literature.
    Kong LZ; Li J; Wang RC; Kang L; Wei Q; Li Y
    Onco Targets Ther; 2021; 14():4551-4559. PubMed ID: 34466001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.
    Abe Y; Ohshima K; Shiratsuchi M; Honda K; Nishimura J; Nawata H; Muta K
    Eur J Haematol; 2001 Mar; 66(3):210-2. PubMed ID: 11350491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
    Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T-cell lymphoma presenting as myelofibrosis with the expression of basic fibroblast growth factor.
    Kikukawa M; Umahara T; Kikawada M; Kanaya K; Sakurai H; Shin K; Mori M; Iwamoto T
    Geriatr Gerontol Int; 2009 Dec; 9(4):395-8. PubMed ID: 20002760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CD20-positive peripheral T-cell lymphoma, not otherwise specified].
    Arai H; Maki K; Tadokoro J; Handa T; Nakamura Y; Tsurumi S; Sasaki K; Mitani K
    Rinsho Ketsueki; 2012 Jul; 53(7):705-9. PubMed ID: 22975773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
    Pileri A; Pellegrini C; Agostinelli C; Grandi V; Patrizi A; Zinzani PL; Pimpinelli N
    Eur J Dermatol; 2017 Feb; 27(1):49-53. PubMed ID: 27873737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary autoimmune myelofibrosis (MF) with high-grade peripheral T-cell lymphoma (PTCL) NOS.
    Jain P; Lin P; Bueso-Ramos C; Verstovsek S; Pemmaraju N
    Eur J Haematol; 2013 Oct; 91(4):378-9. PubMed ID: 23772772
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
    Zhang H; Kheradpour A; Rowsell EH; Zuppan CW; Weiss LM; Wang J
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):e475-80. PubMed ID: 26056791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
    Shibata Y; Hara T; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Goto N; Nannya Y; Ito H; Kito Y; Miyazaki T; Takeuchi T; Saito K; Seishima M; Takami T; Moriwaki H; Shimizu M; Tsurumi H
    Hematol Oncol; 2017 Dec; 35(4):637-644. PubMed ID: 27338762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follicular lymphoma complicated with myelofibrosis and macroglobulinemia at initial presentation].
    Kuroda H; Abe T; Jomen W; Yoshida M; Matsuno T; Sato M; Yamada M; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Murase K; Kato J
    Rinsho Ketsueki; 2013 Nov; 54(11):2068-73. PubMed ID: 24305541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.
    Kim HK; Park CJ; Jang S; Cho YU; Park SH; Choi J; Park CS; Huh J; Chung YH; Lee JH
    Ann Lab Med; 2015 Jan; 35(1):152-4. PubMed ID: 25553299
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
    Tefferi A; Vaidya R; Caramazza D; Finke C; Lasho T; Pardanani A
    J Clin Oncol; 2011 Apr; 29(10):1356-63. PubMed ID: 21300928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
    Niitsu N; Hayama M; Yoshino T; Nakamura S; Tamaru J; Nakamine H; Okamoto M
    Br J Haematol; 2011 Jun; 153(5):582-8. PubMed ID: 21492124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis.
    Liu Z; Medeiros LJ; Young KH
    Hematol Oncol; 2017 Mar; 35(1):125-129. PubMed ID: 25921311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.